Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

High-throughout sequencing of ovarian cancer cells treated with Annonacin and Carboplation

ABSTRACT: High-throughout sequencing of ovarian cancer cells treated with Annonacin and Carboplation

PROVIDER: PRJNA1195834 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR31645656_1.fastq.gz	Fastqsanger.gz
	SRR31645656_2.fastq.gz	Fastqsanger.gz
	SRR31645657_1.fastq.gz	Fastqsanger.gz
	SRR31645657_2.fastq.gz	Fastqsanger.gz
	SRR31645658_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

High-throughout sequencing of ovarian cancer cells treated with YY-15

Project description:High-throughout sequencing of ovarian cancer cells treated with YY-15

| PRJNA1451134 | ENA

High-throughout sequencing of ovarian cancer cells treated with T-oligo

Project description:High-throughout sequencing of ovarian cancer cells treated with T-oligo

| PRJNA1455568 | ENA

High-throughout sequencing of ovarian cancer cells treated with TMPyP4 and H2O2

Project description:High-throughout sequencing of ovarian cancer cells treated with TMPyP4 and H2O2

| PRJNA1090047 | ENA

High-throughout sequencing of liver cancer cells treated Flavokawain C

Project description:High-throughout sequencing of liver cancer cells treated Flavokawain C

| PRJNA1011192 | ENA

High-throughout sequencing of ovarian cancer cells treated with YY-15

Project description:After treating human ovarian cancer cells A2780 and ES2 with YY-15, high-throughput sequencing technology was employed. The transcriptome analysis revealed that YY-15 does not exert its anti-tumor effect solely through telomere dysfunction, but instead simultaneously regulates cell cycle, senescence, apoptosis, and metabolic-related signaling pathways, thereby synergistically inducing the death of ovarian cancer cells.

2026-04-14 | GSE327514 | GEO

High-throughout sequencing of ovarian cancer cells treated with T-oligo

Project description:After treating human ovarian cancer cells ES2 with T-oligo G4+RHPS4, high-throughput sequencing technology was employed. The transcriptome analysis revealed that T-oligo G4+RHPS4 does not exert its anti-tumor effect solely through telomere dysfunction, but instead simultaneously regulates cell cycle, senescence, and metabolic-related signaling pathways, thereby synergistically inducing the death of ovarian cancer cells.

2026-04-23 | GSE328508 | GEO

High-throughout sequencing of ovarian cancer cells treated with Annonacin and Carboplation

Project description:The high-throughput sequencing technology was performed after the treatment of human ovarian cancer cells A2780 and ES2 with Annonacin and Carboplation purchased from MCE, to explore the expression of genes related to cell proliferationand DNA damage of ovarian cancer cells A2780 and ES2 after the treatment of Annonacin and Carboplation, and to find an interesting target pathway,p53 signaling pathway.

2024-12-14 | GSE283821 | GEO

High-throughout sequencing of ovarian cancer cells treated with TMPyP4 and H2O2

Project description:The high-throughput sequencing technology was performed after the treatment of human ovarian cancer cells A2780 with TMPyP4 and H2O2 purchased from Sigma-Aldrich, to explore the expression of genes related to cell proliferation, DNA damage and ROS levels of ovarian cancer cells A2780 after the treatment of TMPyP4 and H2O2, and to find an interesting target pathway,HIF-1 signaling pathway.

2024-03-25 | GSE262015 | GEO

High-throughout sequencing of RAW264.7 cells treated with LPS and Harmine

Project description:High-throughout sequencing of RAW264.7 cells treated with LPS and Harmine

| PRJNA1111748 | ENA

High-throughout sequencing of triple negative breast cancer cells treated actived compound D16

Project description:High-throughout sequencing of triple negative breast cancer cells treated actived compound D16

| PRJNA754393 | ENA